Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Notes Payables (2018 - 2024)

GeoVax Labs' Notes Payables history spans 5 years, with the latest figure at $142292.0 for Q2 2024.

  • Quarterly results put Notes Payables at $142292.0 for Q2 2024, changed N/A from a year ago — trailing twelve months through Jun 2024 was $142292.0 (changed N/A YoY), and the annual figure for FY2020 was $183326.0, up 1366.61%.
  • Notes Payables for Q2 2024 was $142292.0 at GeoVax Labs, down from $182844.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $183326.0 in Q4 2020 to a low of $12048.0 in Q1 2020.
  • The 3-year median for Notes Payables is $182481.5 (2020), against an average of $147578.8.
  • The sharpest move saw Notes Payables decreased 3.62% in 2020, then soared 1417.63% in 2021.
  • Year by year, Notes Payables stood at $183326.0 in 2020, then fell by 0.26% to $182844.0 in 2021, then fell by 22.18% to $142292.0 in 2024.
  • According to Business Quant data, Notes Payables over the past three periods came in at $142292.0, $182844.0, and $183326.0 for Q2 2024, Q1 2021, and Q4 2020 respectively.